Caxton Associates (New York)’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-99,409
Closed -$114K 772
2022
Q1
$114K Buy
99,409
+69,109
+228% +$79.3K 0.01% 441
2021
Q4
$76K Buy
+30,300
New +$76K 0.01% 510